PRANA Biotechnology (PRAN) Announces Share Purchase Plan Closed
5/3/2013 10:52:56 AM
More...
|
PRANA Biotechnology (PRAN) Announces $5.8 Million R&D Refund
4/4/2013 9:27:28 AM
More...
|
PRANA Biotechnology (PRAN) Provides Clinical Trials Safety and Progress Update
4/3/2013 10:47:40 AM
More...
|
PRANA Biotechnology (PRAN) Announces Successful $7.3 Million Capital Raising
3/27/2013 7:22:06 AM
More...
|
PRANA Biotechnology (PRAN) Details Data Showing That PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation
3/8/2013 8:46:12 AM
More...
|
PRANA Biotechnology (PRAN)'s PBT434 Inhibits Accumulation of Parkinson's Protein and Subsequent Death of Brain Cells
3/6/2013 9:16:03 AM
More...
|
PRANA Biotechnology (PRAN) Announces That PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation
3/4/2013 9:14:27 AM
More...
|
PRANA Biotechnology (PRAN) to Present at Cowen and Company Health Care Conference on March 4th in Boston, MA
2/25/2013 10:15:35 AM
More...
|
PRANA Biotechnology (PRAN) Announces That New York Academy of Sciences eBriefing is Available Online
1/29/2013 9:05:46 AM
More...
|
PRANA Biotechnology (PRAN) Completes Recruitment in Huntington Trial
12/19/2012 8:33:38 AM
More...
|
|